HGF/c-Met Axis: A Promising Therapeutic Target and Biomarker for Cancer

Sino Biological has developed a panel of high activity c-MET proteins and HGF proteins

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Wednesday 20 October 2021 View this email online

SPONSORED CONTENT

Mesenchymal-epithelial transition factor (MET), also known as c-Met or Hepatocyte growth factor receptor (HGFR), is a receptor tyrosine kinase (RTK) that is overexpressed or mutated in various malignancies. Aberrantly active MET triggers tumor growth, angiogenesis, and cancer metastasis. MET activity is also critical to embryogenesis. HGF, also known as scatter factor (SF), is the only known ligand of MET. Upon activation, MET engages with a variety of signal transducers at its intracellular multisubstrate docking site to stimulate the Ras/MAPK, JAK/STAT, SRC, PI3K/AKT, Wnt/β-catenin, and other signaling pathways. MET and its associated signaling pathways are clinically important therapeutic targets. A number of small-molecule inhibitors and antibodies targeting MET and HGF are being developed as promising therapeutics for cancer, heart disease, autism, and other diseases. Sino Biological has developed high-quality reagents to support the study of MET signaling.   c-MET and HGF Proteins Sino Biological has developed a panel of high activity c-MET proteins and HGF proteins from various species to help study the biology of MET signaling. Human c-MET Protein | 10692-H20B1   Cynomolgus c-MET Protein | 90304-C08H Purity: > 90% as determined by SDS-PAGE Activity: • The specific activity was determined to be 10 nmol/min/mg using MBP as substrate. • Binding ability with HGF measured by functional ELISA. Binding ability measured by ELISA. Immobilized human HGF (Cat: 10463-HNAS) at 10 µg/mL (100 µL/well) can bind canine c-MET. The EC50 is 7 ng/mL. Human HGF Protein | 10463-HNAS Cynomolgus HGF Protein | 90286-CNAH Ability to neutralize TGF-beta mediated inhibition on Mv-1-Lu cell proliferation. The ED50 is typically 0.5-5 ng/mL. Ability to inhibit TGFβ1 activity on Mv-1-lu mink lung epithelial cells. The ED50 is typically 2-10 ng/mL. • Recommended c-MET and HGF Proteins Please visit #Sino Biological to search for these products. Catalog #   Species Molecule Tag Expressed Host Activity 10692-H20B1 Human c-MET N-GST & His Insect Cells Active 50622-M02H Mouse c-MET C-human IgG1-Fc HEK293 Cells Active 50622-M08H Mouse c-MET C-His HEK293 Cells Active 70008-D08H Canine c-MET C-His HEK293 Cells Active 80004-R02H Rat c-MET C-human IgG1-Fc HEK293 Cells Active 90304-C02H Cynomolgus, Rhesus c-MET C-human IgG1-Fc HEK293 Cells Active 90304-C08H Cynomolgus, Rhesus c-MET C-His HEK293 Cells Active 90304-CCCH Cynomolgus, Rhesus c-MET C-cleavage HEK293 Cells Active 10463-HNAS Human HGF Native CHO Cells Active 50038-M08H Mouse HGF C-His HEK293 Cells Active 50038-MNAH Mouse HGF Native HEK293 Cells Active 70063-DNAH Canine HGF Native HEK293 Cells   80429-RNAH Rat HGF Native HEK293 Cells Active 90286-CNAH Cynomolgus HGF Native HEK293 Cells Active   Anti-c-MET and Anti-HGF Antibodies Sino Biological has developed a comprehensive panel of antibodies targeting MET and HGF, which can be used in ELISA, FCM, IHC, WB, as well as neutralization. ELISA kits and ELISA pair sets are also available. Cell Proliferation was Inhibited by Human HGF Antibody | 10463-mh010 Flow Cytometric Analysis of Human c-Met Expression on HepG2 Cells | 10692-R243 Proliferation of U87 MG cells elicited by autocrine HGF was inhibited by increasing concentrations of Human HGF Neutralizing Monoclonal Antibody. The IC50 is typically 1-4 µg/mL. Cells were stained with purified anti-Human c-Met, second antibody conjugated with FITC. • More Antibodies of c-MET and HGF Anti-c-MET Antibodies   Anti-HGF Antibodies Sino Biological US Inc. +1-215-583-7898   order_us@sinobiologicalus.com cro_us@sinobiologicalus.com 1400 Liberty Ridge Drive, Suite 101, Wayne, PA 19087

© Future US, Inc., 11 W 42nd Street, 15th Floor, New York, NY 10036. This email is intended for submitpostforlive@gmail.com To unsubscribe from Live Science emails or update your email preferences, please click here. Privacy Policy | Cookies Policy | Terms and Conditions